Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
WuXi PharmaTech will pay $151 million to acquire...
The ChinaBio® Stock Index, comprised of 17...
Sundia MediTech Company, a Shanghai-based CRO, has...
There were two items of broad significance and a host of...
NovaMed Pharmaceuticals Inc., a CRO and out-sourced...
WuXi PharmaTech held a conference yesterday with its...
KPMG released a 2008 venture capital forecast, drawn from...
The China CRO industry received coverage last...
Charles River Labs said its China CRO work comes...
According to China Central TV, Novartis produced 2.5...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China